http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102030207-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2012-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102030207-B1 |
| titleOfInvention | Synthesis of Polyhydroxy Chromenone Compounds and Their Anti-Tumor Effect |
| abstract | The present invention provides a polyhydroxy benzopyran ketone compound having a structure represented by the following formula (I) and a pharmaceutically acceptable salt or prodrug thereof, as well as a pharmaceutical composition containing the compound. The compounds are used to modulate and control novel estrogen receptor ER-α36, or to prevent and / or treat ER-α36 receptor-mediated tumor associated diseases such as breast cancer, leukemia and liver cancer. Formula (I) |
| priorityDate | 2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.